Morepen Laboratories Limited
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and hom… Read more
Morepen Laboratories Limited (MOREPENLAB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.011x
Based on the latest financial reports, Morepen Laboratories Limited (MOREPENLAB) has a cash flow conversion efficiency ratio of 0.011x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹130.45 Million) by net assets (₹11.97 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Morepen Laboratories Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Morepen Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Morepen Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Morepen Laboratories Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pollard Banknote Limited
PINK:PBKOF
|
0.073x |
|
Shin Ruenn Development Co Ltd
TWO:6186
|
0.299x |
|
China Aluminum International Engineering Corporation Limited
F:4AI
|
0.090x |
|
VinFast Auto Ltd.
F:0TL
|
0.113x |
|
SKYX Platforms Corp
NASDAQ:SKYX
|
-4.295x |
|
7707
TWO:7707
|
-0.037x |
|
AC Immune Ltd
NASDAQ:ACIU
|
-0.294x |
|
Nex Point Public Company Limited
BK:NEX
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Morepen Laboratories Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Morepen Laboratories Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹11.87 Billion | ₹320.57 Million | 0.027x | -68.82% |
| 2024-03-31 | ₹8.47 Billion | ₹733.75 Million | 0.087x | +171.48% |
| 2023-03-31 | ₹7.52 Billion | ₹-911.71 Million | -0.121x | -21.28% |
| 2022-03-31 | ₹5.78 Billion | ₹-577.58 Million | -0.100x | -183.40% |
| 2021-03-31 | ₹4.24 Billion | ₹508.26 Million | 0.120x | +208.36% |
| 2020-03-31 | ₹2.84 Billion | ₹110.17 Million | 0.039x | -43.50% |
| 2019-03-31 | ₹2.53 Billion | ₹173.71 Million | 0.069x | -75.55% |
| 2018-03-31 | ₹2.25 Billion | ₹634.14 Million | 0.281x | +43.11% |
| 2017-03-31 | ₹3.23 Billion | ₹635.12 Million | 0.197x | +17.61% |
| 2016-03-31 | ₹3.00 Billion | ₹500.71 Million | 0.167x | -5.38% |
| 2015-03-31 | ₹2.87 Billion | ₹507.00 Million | 0.177x | +56.37% |
| 2014-03-31 | ₹2.97 Billion | ₹335.10 Million | 0.113x | +0.53% |
| 2013-03-31 | ₹2.99 Billion | ₹336.40 Million | 0.112x | +32.59% |
| 2012-03-31 | ₹3.20 Billion | ₹271.10 Million | 0.085x | +326.96% |
| 2011-03-31 | ₹4.52 Billion | ₹89.77 Million | 0.020x | +34.60% |
| 2010-03-31 | ₹4.52 Billion | ₹66.69 Million | 0.015x | +13.53% |
| 2009-03-31 | ₹3.51 Billion | ₹45.61 Million | 0.013x | +25.28% |
| 2008-03-31 | ₹7.96 Billion | ₹82.53 Million | 0.010x | -97.54% |
| 2007-03-31 | ₹6.41 Billion | ₹2.70 Billion | 0.421x | +201.24% |
| 2006-03-31 | ₹2.71 Billion | ₹379.23 Million | 0.140x | +216.85% |
| 2005-03-31 | ₹2.43 Billion | ₹-290.22 Million | -0.120x | -- |